美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
60219-2045-7	60219-2045	HUMAN PRESCRIPTION DRUG	theophylline	theophylline	TABLET, EXTENDED RELEASE	ORAL	20230327	N/A	ANDA	ANDA216276	Amneal Pharmaceuticals NY LLC	THEOPHYLLINE ANHYDROUS	300 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2045-7)
60219-2046-1	60219-2046	HUMAN PRESCRIPTION DRUG	theophylline	theophylline	TABLET, EXTENDED RELEASE	ORAL	20230327	N/A	ANDA	ANDA216276	Amneal Pharmaceuticals NY LLC	THEOPHYLLINE ANHYDROUS	450 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2046-1)
60219-2046-3	60219-2046	HUMAN PRESCRIPTION DRUG	theophylline	theophylline	TABLET, EXTENDED RELEASE	ORAL	20230327	N/A	ANDA	ANDA216276	Amneal Pharmaceuticals NY LLC	THEOPHYLLINE ANHYDROUS	450 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2046-3)
60219-2046-5	60219-2046	HUMAN PRESCRIPTION DRUG	theophylline	theophylline	TABLET, EXTENDED RELEASE	ORAL	20230327	N/A	ANDA	ANDA216276	Amneal Pharmaceuticals NY LLC	THEOPHYLLINE ANHYDROUS	450 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2046-5)
60219-2045-5	60219-2045	HUMAN PRESCRIPTION DRUG	theophylline	theophylline	TABLET, EXTENDED RELEASE	ORAL	20230327	N/A	ANDA	ANDA216276	Amneal Pharmaceuticals NY LLC	THEOPHYLLINE ANHYDROUS	300 mg/1	500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2045-5)
60219-2045-3	60219-2045	HUMAN PRESCRIPTION DRUG	theophylline	theophylline	TABLET, EXTENDED RELEASE	ORAL	20230327	N/A	ANDA	ANDA216276	Amneal Pharmaceuticals NY LLC	THEOPHYLLINE ANHYDROUS	300 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2045-3)
60219-2045-1	60219-2045	HUMAN PRESCRIPTION DRUG	theophylline	theophylline	TABLET, EXTENDED RELEASE	ORAL	20230327	N/A	ANDA	ANDA216276	Amneal Pharmaceuticals NY LLC	THEOPHYLLINE ANHYDROUS	300 mg/1	100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60219-2045-1)